Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastiaan Engelborghs

Showing results (311-320 of 359) with videos related to

Pageof 36
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 15, 2021
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levelsShengjun Hong, Valerija Dobricic, Olena Ohlei, et al.
Neurobiology of Aging|March 21, 2018
Rare nonsynonymous variants in SORT1 are associated with increased risk for frontotemporal dementiaStéphanie Philtjens, Sara Van Mossevelde, Julie van der Zee, et al.
Neurobiology of Aging|March 23, 2015
Genetic variability in SQSTM1 and risk of early-onset Alzheimer dementia: a European early-onset dementia consortium studyElise Cuyvers, Julie van der Zee, Karolien Bettens, et al.
Genome Medicine|October 4, 2023
Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioningAlexander Neumann, Olena Ohlei, Fahri Küçükali, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 1, 2020
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohortDaniel Stamate, Min Kim, Petroula Proitsi, et al.
Human Mutation|September 29, 2015
Rare Variants in PLD3 Do Not Affect Risk for Early-Onset Alzheimer Disease in a European Consortium CohortRita Cacace, Tobi Van den Bossche, Sebastiaan Engelborghs, et al.
Neurobiology of Aging|June 22, 2015
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory studyNiels Kruse, Staffan Persson, Daniel Alcolea, et al.
Neurobiology of Aging|May 9, 2017
The frequency and influence of dementia risk factors in prodromal Alzheimer's diseaseIsabelle Bos, Stephanie J Vos, Lutz Frölich, et al.
Translational Psychiatry|November 23, 2020
Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery datasetShengjun Hong, Dmitry Prokopenko, Valerija Dobricic, et al.
Nature Genetics|September 8, 2009
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's diseaseJean-Charles Lambert, Simon Heath, Gael Even, et al.
Pageof 36

Showing results (311-320 of 359) with videos related to

Sort By:
Pageof 36
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 15, 2021
TMEM106B and CPOX are genetic determinants of cerebrospinal fluid Alzheimer's disease biomarker levelsShengjun Hong, Valerija Dobricic, Olena Ohlei, et al.
Neurobiology of Aging|March 21, 2018
Rare nonsynonymous variants in SORT1 are associated with increased risk for frontotemporal dementiaStéphanie Philtjens, Sara Van Mossevelde, Julie van der Zee, et al.
Neurobiology of Aging|March 23, 2015
Genetic variability in SQSTM1 and risk of early-onset Alzheimer dementia: a European early-onset dementia consortium studyElise Cuyvers, Julie van der Zee, Karolien Bettens, et al.
Genome Medicine|October 4, 2023
Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioningAlexander Neumann, Olena Ohlei, Fahri Küçükali, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 1, 2020
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohortDaniel Stamate, Min Kim, Petroula Proitsi, et al.
Human Mutation|September 29, 2015
Rare Variants in PLD3 Do Not Affect Risk for Early-Onset Alzheimer Disease in a European Consortium CohortRita Cacace, Tobi Van den Bossche, Sebastiaan Engelborghs, et al.
Neurobiology of Aging|June 22, 2015
Validation of a quantitative cerebrospinal fluid alpha-synuclein assay in a European-wide interlaboratory studyNiels Kruse, Staffan Persson, Daniel Alcolea, et al.
Neurobiology of Aging|May 9, 2017
The frequency and influence of dementia risk factors in prodromal Alzheimer's diseaseIsabelle Bos, Stephanie J Vos, Lutz Frölich, et al.
Translational Psychiatry|November 23, 2020
Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery datasetShengjun Hong, Dmitry Prokopenko, Valerija Dobricic, et al.
Nature Genetics|September 8, 2009
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's diseaseJean-Charles Lambert, Simon Heath, Gael Even, et al.
Pageof 36